0.38  0 (0%)		12-30 16:00
Open: 0.3699 High: 0.4789 Volume: 5,811,488		Pre. Close: 0.38 Low: 0.32 Market Cap: 0(M)

Short term
Mid term
Targets	6-month :		1-year :
Resists	First :		Second :
Pivot price
Supports	First :		Second :
MAs	MA(5) :		MA(20) :
	MA(100) :		MA(250) :
MACD	MACD :		Signal :
%K %D	K(14,3) :		D(3) :
RSI	RSI(14):
52-week	High :		Low :

If tomorrow:	Open lower	Open higher
High:	-	-
Low:	-	-
Close:	-	-

Quotient Limited is a diagnostics firm in the commercial stage, dedicated to the creation, production, marketing, and distribution of solutions for the global transfusion diagnostics sector. The company's reach extends across the United States, France, Japan, and other international territories. A central element of their product portfolio is MosaiQ, an exclusive technological platform. This system delivers extensive testing capabilities for immunohematology, alongside serological and molecular disease screening applications. Beyond the innovative MosaiQ platform, Quotient also provides traditional reagent products essential for blood grouping. These include antisera for identifying blood group antigens; reagent red blood cells designed to detect blood group antibodies; whole blood control products for daily quality assurance; and various ancillary items that support blood group analysis. Their specialized MosaiQ microarrays include several offerings: the SDS Microarray, crafted for serological disease screening to pinpoint cytomegalovirus and Syphilis; the MDS Microarray, which conducts molecular disease screening on donor red cells or source plasma; the IH Microarray for blood grouping; an Autoimmune Microarray; a COVID-19 specific array; and the IH3 Microarray. Quotient's diverse customer base encompasses healthcare institutions such as hospitals, blood donation centers, independent testing facilities, original equipment manufacturers, blood banking operations, and other diagnostic companies. Founded in 2007, the company maintains its headquarters in Eysins, Switzerland.

Mon, 09 Jan 2023
Quotient Ltd (QTNT) Share Price Today | Quotient (QTNT) Live NSE/BSE - Value Research

Wed, 26 Oct 2022
Sannova Appoints Jason Apter as CEO - citybiz

Tue, 30 Nov 2021
Quotient Appoints Esteban Uriarte as Chief Manufacturing Operations Officer - citybiz

Tue, 23 Feb 2021
Quotient Appoints Manuel Mendez as CEO - citybiz

Thu, 21 Apr 2016
Quotient Awarded UK's Highest Accolade for Business Success - PR Newswire UK

Sat, 01 Aug 2026

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Outperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	(%)
Held by Institutions	(%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS
EPS Est Next Qtrly
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin	%
Operating Margin	%
Return on Assets (ttm)	%
Return on Equity (ttm)	%
Qtrly Rev. Growth	%
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth	%
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow

Dividend
Forward Dividend
Dividend Yield	0%
Dividend Pay Date
Ex-Dividend Date